RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D, obesity, and COVID-19 drug candidates.

Biotechnology

RosVivo Therapeutics

Junghak Kim

Rajan Singh

Sandra Poudrier

Seungil Ro

Seeun Ha

The Research and Advisory Team at RosVivo Therapeutics conducts cutting-edge scientific research to advance miRNA and siRNA therapies, focusing on type 2 diabetes, obesity, and COVID-19. The team leverages unique insights to drive the development of novel drug candidates and diagnostic tests while providing strategic direction and expert consultation to guide the company's therapeutic pipeline.

Research and Advisory Team

About

Team members

Other teams at RosVivo Therapeutics

Leadership Team